10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2021 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Revenues: | |||
| Total revenues | $ 25,979 | 25,424 | 23,362 |
| Operating expenses: | |||
| Cost of sales | 6,454 | 6,159 | 4,356 |
| Research and development | 4,819 | 4,207 | 4,116 |
| Acquired in-process research and development | 1,505 | 0 | 0 |
| Selling, general and administrative | 5,368 | 5,730 | 5,150 |
| Other | 194 | 189 | 66 |
| Total operating expenses | 18,340 | 16,285 | 13,688 |
| Operating income | 7,639 | 9,139 | 9,674 |
| Interest expense, net | (1,197) | (1,262) | (1,289) |
| Other income, net | 259 | 256 | 753 |
| Income before income taxes | 6,701 | 8,133 | 9,138 |
| Provision for income taxes | 808 | 869 | 1,296 |
| Net income | 5,893 | 7,264 | 7,842 |
| Earnings per share: | |||
| Basic (in usd per share) | 10.34 | 12.40 | 12.96 |
| Diluted (in usd per share) | 10.28 | 12.31 | 12.88 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 570 | 586 | 605 |
| Diluted (in shares) | 573 | 590 | 609 |
| Product and Service | |||
| Product sales | |||
| Total revenues | 24,297 | 24,240 | 22,204 |
| Other revenues | |||
| Total revenues | 1,682 | 1,184 | 1,158 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2021 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Net income | $ 5,893 | 7,264 | 7,842 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| (Losses) gains on foreign currency translation | (135) | 9 | (48) |
| Gains (losses) on cash flow hedges | 324 | (438) | (66) |
| (Losses) gains on available-for-sale securities | (1) | (21) | 360 |
| Other | 1 | (7) | (5) |
| Other comprehensive income (loss), net of taxes | 189 | (457) | 241 |
| Comprehensive income | 6,082 | 6,807 | 8,083 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Cash flows from operating activities: | |||
| Net income | $ 5,893 | 7,264 | 7,842 |
| Depreciation, amortization and other | 3,398 | 3,601 | 2,206 |
| Stock-based compensation expense | 341 | 330 | 308 |
| Deferred income taxes | (453) | (287) | (289) |
| Acquired in-process research and development | 1,505 | 0 | 0 |
| Other items, net | (229) | (195) | (186) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (429) | (427) | (504) |
| Inventories | (165) | (215) | (66) |
| Other assets | (237) | 129 | 10 |
| Accounts payable | (69) | 45 | 164 |
| Accrued income taxes, net | (854) | (249) | (585) |
| Long-term tax liabilities | 204 | (482) | (146) |
| Other liabilities | 356 | 983 | 396 |
| Net cash provided by operating activities | 9,261 | 10,497 | 9,150 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (8,900) | (8,477) | (9,394) |
| Proceeds from sales of marketable securities | 4,403 | 2,597 | 8,842 |
| Proceeds from maturities of marketable securities | 8,831 | 4,381 | 20,548 |
| Purchases of property, plant and equipment | (880) | (608) | (618) |
| Cash paid for acquisitions, net of cash acquired | (2,529) | 0 | (13,617) |
| Purchases of equity method investments | (157) | (3,219) | (24) |
| Other | (35) | (75) | (28) |
| Net cash provided by (used in) investing activities | 733 | (5,401) | 5,709 |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,945 | 8,914 | 0 |
| Repayment of debt | (4,150) | (6,450) | (4,514) |
| Repurchases of common stock | (4,975) | (3,486) | (7,702) |
| Dividends paid | (4,013) | (3,755) | (3,509) |
| Other | (78) | (90) | (42) |
| Net cash used in financing activities | (8,271) | (4,867) | (15,767) |
| Increase (decrease) in cash and cash equivalents | 1,723 | 229 | (908) |
| Cash and cash equivalents at beginning of year | 6,266 | 6,037 | |
| Cash and cash equivalents at end of year | 7,989 | 6,266 | 6,037 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2021 | Dec 31, 2020 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 7,989 | 6,266 |
| Marketable securities | 48 | 4,381 |
| Trade receivables, net | 4,895 | 4,525 |
| Inventories | 4,086 | 3,893 |
| Other current assets | 2,367 | 2,079 |
| Total current assets | 19,385 | 21,144 |
| Property, plant and equipment, net | 5,184 | 4,889 |
| Intangible assets, net | 15,182 | 16,587 |
| Goodwill | 14,890 | 14,689 |
| Other noncurrent assets | 6,524 | 5,639 |
| Total assets | 61,165 | 62,948 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,366 | 1,421 |
| Accrued liabilities | 10,731 | 10,141 |
| Current portion of long-term debt | 87 | 91 |
| Total current liabilities | 12,184 | 11,653 |
| Long-term debt | 33,222 | 32,895 |
| Long-term tax liabilities | 6,594 | 6,968 |
| Other noncurrent liabilities | 2,465 | 2,023 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding558.3 shares in 2021 and 578.3 shares in 2020 | 32,096 | 31,802 |
| Accumulated deficit | (24,600) | (21,408) |
| Accumulated other comprehensive loss | (796) | (985) |
| Total stockholders equity | 6,700 | 9,409 |
| Total liabilities and stockholders equity | 61,165 | 62,948 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |